Back to Search Start Over

Do symptoms of depression, anxiety or stress impair the effectiveness of cognitive behavioural therapy for insomnia? A chart-review of 455 patients with chronic insomnia.

Authors :
Sweetman, Alexander
Lovato, Nicole
Micic, Gorica
Scott, Hannah
Bickley, Kelsey
Haycock, Jenny
Harris, Jodie
Gradisar, Michael
Lack, Leon
Source :
Sleep Medicine. Nov2020, Vol. 75, p401-410. 10p.
Publication Year :
2020

Abstract

<bold>Background: </bold>Co-occurring insomnia and symptoms of depression, anxiety, and stress pose difficult diagnostic and treatment decisions for clinicians. Cognitive Behavioural Therapy for Insomnia (CBTi) is the recommended first-line insomnia treatment, however symptoms of depression, anxiety and stress may reduce the effectiveness of CBTi. We examined the effect of low, moderate, and severe symptoms of depression, anxiety, and stress on insomnia improvements during CBTi.<bold>Methods: </bold>We undertook a chart-review of 455 patients (67% Female, Age M = 51.7, SD = 15.6) attending an outpatient CBTi program. Sleep diaries and questionnaire measures of insomnia, depression, anxiety, and stress symptoms were completed at pre-treatment, post-treatment and three-month follow up. We examined 1) the effect of low, moderate, and severe symptoms of depression, anxiety, and stress before treatment on changes in sleep diary and questionnaire measures of insomnia during CBTi, and 2) changes in symptoms of depression, anxiety, and stress during CBTi.<bold>Results: </bold>Sleep diary and questionnaire measures of insomnia severity showed moderate-to-large improvements during CBTi (d = 0.5-2.7, all p ≤ 0.001), and were not moderated by levels of depression, anxiety or stress before treatment (all interactions p > 0.05). Symptoms of depression, anxiety, and stress improved by three-month follow-up (M improvement = 41-43%; CI = 28-54, Cohen's d = 0.4-0.7).<bold>Conclusions: </bold>Symptoms of depression, anxiety, and stress do not impair the effectiveness of CBTi. Instead, CBTi was associated with moderate-to-large improvement of depression, anxiety, and stress symptoms in patients with insomnia disorder. Clinicians should refer patients with insomnia for CBTi even in the presence of comorbid symptoms of depression, anxiety, and stress. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
13899457
Volume :
75
Database :
Academic Search Index
Journal :
Sleep Medicine
Publication Type :
Academic Journal
Accession number :
146997525
Full Text :
https://doi.org/10.1016/j.sleep.2020.08.023